zidovudine (Cipla Ltd.)
Welcome to the PulseAid listing for the zidovudine drug offered from Cipla Ltd.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cipla Ltd. |
NON-PROPRIETARY NAME: | zidovudine |
SUBSTANCE NAME: | ZIDOVUDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | SYRUP |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2008-06-26 |
END MARKETING DATE: | 0000-00-00 |
zidovudine HUMAN PRESCRIPTION DRUG Details:
Item Description | zidovudine from Cipla Ltd. |
LABELER NAME: | Cipla Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/5mL) |
START MARKETING DATE: | 2008-06-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53104-0105_ffd1d1d8-f8e4-40d5-b7cb-b78af6741a84 |
PRODUCT NDC: | 53104-0105 |
APPLICATION NUMBER: | ANDA077981 |
Other ZIDOVUDINE Pharmaceutical Manufacturers / Labelers: